MEI Pharma's 15-minute chart sees MACD Death Cross, KDJ Death Cross.

Based on the 15-minute chart for MEI Pharma, the MACD and KDJ indicators have recently triggered a "death cross" and "death cross" respectively, as of August 6th at 09:45. This suggests that the stock price has the potential to continue declining, with the momentum shifting towards a downward trend and potentially leading to further decreases in value.

On August 6, 2025, at 09:45, MEI Pharma's 15-minute chart triggered significant technical indicators that suggest a potential downward trend in the stock price. The combination of the MACD and KDJ indicators, known as the "death cross," signals a shift in momentum towards a downward trajectory [1].

The MACD and KDJ indicators are technical analysis tools that help traders and investors identify potential reversals in price trends. The MACD (Moving Average Convergence Divergence) is a trend-following momentum indicator that shows the relationship between two moving averages of a security's price. The KDJ (Kaufman Adaptive Moving Average) is a momentum oscillator that measures the strength of a trend. When these indicators cross in a bearish manner, as seen in MEI Pharma's chart, it often indicates a potential sell signal [1].

In addition to these technical indicators, the presence of a Bearish Marubozu candle at the same time suggests that sellers are currently controlling the market. A Marubozu candle is characterized by a large body with no upper or lower shadows, indicating strong buying or selling pressure. In this case, the Bearish Marubozu candle signifies that sellers are dominant, which could lead to further declines in the stock price [1].

MEI Pharma's recent strategic move to invest $100 million in Litecoin (LTC) as a treasury asset may have overshadowed the company's cryptocurrency investments. This move, which positions MEI Pharma as a pioneer in adopting a major cryptocurrency as a primary treasury holding, could add complexity to its financial strategy [2]. However, the recent technical indicators on MEI Pharma's 15-minute chart may influence the stock's performance in the near term.

Investors should closely monitor MEI Pharma's regulatory pathway discussions with the FDA and any potential partnering announcements, as these events could impact the stock's performance. The company's focus on Litecoin as a treasury asset adds a layer of complexity to its financial strategy, and investors should be aware of the associated risks, including regulatory scrutiny and price volatility.

References:
[1] https://www.ainvest.com/news/mei-pharma-15min-chart-triggered-kdj-death-cross-bearish-marubozu-signal-2508/
[2] https://en.coinotag.com/mei-pharmas-100m-move-to-litecoin-exploring-potential-impacts-on-market-dynamics-and-institutional-adoption/